US Patent Issued to The United States of America, as represented by the Secretary, Department of Health and Human Services, University of Maryland, College Park on July 29 for "Il-7R-alpha specific antibodies for treating acute lymphoblastic leukemia" (Maryland Inventors)

ALEXANDRIA, Va., July 30 -- United States Patent no. 12,371,500, issued on July 29, was assigned to The United States of America, as represented by the Secretary, Department of Health and Human Services (Bethesda, Md.) and University of Maryland, College Park (College Park, Md.).

"Il-7R-alpha specific antibodies for treating acute lymphoblastic leukemia" was invented by Scott Durum (Frederick, Md.), Julie Hixon (Hagerstown, Md.), Wen Qing Li (Frederick, Md.), Scott Walsh (College Park, Md.) and Lila Kashi (College Park, Md.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Antibodies and antigen binding fragments that specifically bind to IL-7RAlpha are disclosed. Nucleic acids encoding the antibodies and antig...